|
|
||||||||
The FASEB Journal, Vol 8, 639-645, Copyright © 1994 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
LA Caron-Leslie, RB Evans and JA Cidlowski
Department of Physiology, University of North Carolina at Chapel Hill 27599.
Many non-Hodgkins B-cell lymphomas possess a deregulated bcl-2 gene resulting in a phenotype that is apparently resistant to programmed cell death (apoptosis). We have used a mouse lymphoma cell line (S49.1) that undergoes apoptosis in response to a variety of stimuli to determine the effect of bcl-2 expression on induction of apoptosis. S49 cells were stably transfected with recombinant amphotrophic retroviruses carrying either a G418 antibiotic resistance gene alone (S49-NEO) or this gene in combination with a bcl-2 complementary DNA (S49-Bcl-2). Three different agents previously shown to activate apoptosis by different pathways in S49 cells (dexamethasone, the calcium ionophore A23187, and cycloheximide) were used to examine the effect of bcl-2 expression on cell growth and apoptosis caused by multiple signal transduction pathways. Dexamethasone (DEX) treatment inhibited cell growth and stimulated cell death in S49-NEO cells. Although S49-Bcl-2 cells exhibited a similar antiproliferative response, they failed to die in response to steroid treatment. Western blot analysis revealed no difference in the levels of glucocorticoid receptor protein in the two cell lines, and both responded to glucocorticoid with a profound inhibition of protein synthesis. Cycloheximide (CX) and A23187 also had antiproliferative and cell killing effects in both cell types, although higher concentrations of each agent were needed to kill S49-Bcl-2 cells. To determine whether the loss of viability in response to these drugs was due to apoptosis, cells were examined morphologically and DNA integrity was examined by gel electrophoresis.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
L. Rocha-Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci Glucocorticoids Repress bcl-X Expression in Lymphoid Cells by Recruiting STAT5B to the P4 Promoter J. Biol. Chem., November 10, 2006; 281(45): 33959 - 33970. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Almawi, O. K. Melemedjian, and M. M. A. Jaoude On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis J. Leukoc. Biol., July 1, 2004; 76(1): 7 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Rose, B. E. Smith, and D. G. Maloney Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects Blood, August 13, 2002; 100(5): 1765 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-T. J. HUANG and J. A. CIDLOWSKI Phosphorylation status modulates Bcl-2 function during glucocorticoid-induced apoptosis in T lymphocytes FASEB J, June 1, 2002; 16(8): 825 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang and P. A. Insel Bcl-2 protects lymphoma cells from apoptosis but not growth arrest promoted by cAMP and dexamethasone Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1642 - C1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. Leussink, S. Jung, U. Merschdorf, K. V. Toyka, and R. Gold High-Dose Methylprednisolone Therapy in Multiple Sclerosis Induces Apoptosis in Peripheral Blood Leukocytes Arch Neurol, January 1, 2001; 58(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yan, V. Herrmann, J. K. Hofer, and P. A. Insel beta -Adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells Am J Physiol Cell Physiol, November 1, 2000; 279(5): C1665 - C1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Majlessi and G. Bordenave Non-overlapping Fas- and BCL-2-regulated death pathways in IgG2ab-producing B cells Int. Immunol., July 1, 2000; 12(7): 969 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gohel, M.-B. McCarthy, and G. Gronowicz Estrogen Prevents Glucocorticoid-Induced Apoptosis in Osteoblasts in Vivo and in Vitro Endocrinology, November 1, 1999; 140(11): 5339 - 5347. [Abstract] [Full Text] |
||||
![]() |
S.-T. J. HUANG and J. A. CIDLOWSKI Glucocorticoids inhibit serum depletion-induced apoptosis in T lymphocytes expressing Bcl-2 FASEB J, March 1, 1999; 13(3): 467 - 476. [Abstract] [Full Text] |
||||
![]() |
B. L. Spangelo, D. D. Farrimond, M. Thapa, C. M. Bulathsinghala, K.-L. Bowman, A. Sareh, F. M. Hughes Jr., A. L. Goldstein, and M. Badamchian Thymosin Fraction 5 Inhibits the Proliferation of the Rat Neuroendocrine MMQ Pituitary Adenoma and C6 Glioma Cell Lines in Vitro Endocrinology, April 1, 1998; 139(4): 2155 - 2162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sawa, A. A. Khan, L. D. Hester, and S. H. Snyder Glyceraldehyde-3-phosphate dehydrogenase: Nuclear translocation participates in neuronal and nonneuronal cell death PNAS, October 14, 1997; 94(21): 11669 - 11674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cho, L. Mitchell, D. Koopmans, and B. L. Langille Effects of Changes in Blood Flow Rate on Cell Death and Cell Proliferation in Carotid Arteries of Immature Rabbits Circ. Res., September 19, 1997; 81(3): 328 - 337. [Abstract] [Full Text] |
||||
![]() |
P. Zhou, L. Qian, K. M. Kozopas, and R. W. Craig Mcl-1, a Bcl-2 Family Member, Delays the Death of Hematopoietic Cells Under a Variety of Apoptosis-Inducing Conditions Blood, January 15, 1997; 89(2): 630 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Scoltock, C. D. Bortner, G. St. J. Bird, J. W. Putney Jr., and J. A. Cidlowski A Selective Requirement for Elevated Calcium in DNA Degradation, but Not Early Events in Anti-Fas-induced Apoptosis J. Biol. Chem., September 22, 2000; 275(39): 30586 - 30596. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |